LIANG ZHU: Open Payments
NPI 1720528532 · ARCADIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,274 in 50 payments from 12 companies in 2025. Trend: 2023 $2,945 · 2024 $1,784 · 2025 $1,274
Food & beverage: $1,197Education: $77
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $274 |
| Madrigal Pharmaceuticals | 8 | $244 |
| ABBVIE INC. | 12 | $194 |
| PFIZER INC. | 3 | $180 |
| Ardelyx, Inc. | 3 | $165 |
| Phathom Pharmaceuticals, Inc. | 2 | $51 |
| Novo Nordisk Inc | 2 | $40 |
| Boston Scientific Corporation | 1 | $32 |
| Ipsen Biopharmaceuticals, Inc | 1 | $32 |
| Celltrion USA Inc. | 1 | $27 |
Products named: TREMFYA, REZDIFFRA, VELSIPITY, IBSRELA, LINZESS, CREON, VOQUEZNA, Wegovy.
Industry payments across CA — which companies pay providers there.
